Stockscreener 앱 받기
63.85
2.74%
-1.80
시간 외 거래:
49.99
-13.86
-21.71%
전일 마감가:
$65.65
열려 있는:
$65.54
하루 거래량:
2.59M
Relative Volume:
1.42
시가총액:
$3.39B
수익:
-
순이익/손실:
$-38.99M
주가수익비율:
-21.31
EPS:
-2.9966
순현금흐름:
$-24.94M
1주 성능:
-7.01%
1개월 성능:
+7.84%
6개월 성능:
-15.13%
1년 성능:
+13.73%
1일 변동 폭
$63.75
$67.42
1주일 범위
$63.75
$72.80
52주 변동 폭
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
명칭
Soleno Therapeutics Inc
전화
650-213-8444
주소
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
SLNO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
63.85 | 3.49B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-07 | 개시 | Goldman | Buy |
| 2025-08-20 | 개시 | Wells Fargo | Overweight |
| 2025-06-23 | 개시 | TD Cowen | Buy |
| 2025-03-05 | 재개 | Stifel | Buy |
| 2024-12-02 | 재확인 | Robert W. Baird | Outperform |
| 2024-12-02 | 재확인 | Stifel | Buy |
| 2024-09-03 | 개시 | H.C. Wainwright | Buy |
| 2024-05-10 | 개시 | Robert W. Baird | Outperform |
| 2024-02-05 | 개시 | Piper Sandler | Overweight |
| 2024-01-23 | 개시 | Stifel | Buy |
| 2023-11-21 | 재개 | Guggenheim | Buy |
| 2020-09-29 | 개시 | Guggenheim | Buy |
| 2020-01-10 | 개시 | Craig Hallum | Buy |
| 2019-12-23 | 개시 | Oppenheimer | Outperform |
| 2018-02-13 | 재확인 | Maxim Group | Buy |
모두보기
Soleno Therapeutics Inc 주식(SLNO)의 최신 뉴스
Earnings call transcript: Soleno Therapeutics Q3 2025 earnings beat expectations - Investing.com
Soleno Therapeutics tumbles despite Q3 earnings, revenue beat By Investing.com - Investing.com UK
SOLENO THERAPEUTICS INC SEC 10-Q Report - TradingView
Earnings Flash (SLNO) Soleno Therapeutics, Inc. Reports Q3 Revenue $66.0M, vs. FactSet Est of $48.1M - MarketScreener
Soleno Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on U.S. Launch of VYKAT(TM) XR - The Manila Times
Soleno Therapeutics Turns A Profit Thanks To VYKAT XR - Finimize
Full technical analysis of Soleno Therapeutics Inc. stock2025 Macro Impact & Verified Momentum Stock Ideas - newser.com
Can Soleno Therapeutics Inc. stock outperform in 2025 bull marketWeekly Investment Report & Weekly Stock Performance Updates - newser.com
Real time social sentiment graph for Soleno Therapeutics Inc.July 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Will Soleno Therapeutics Inc. (6XC) stock outperform small cap peersJuly 2025 Macro Moves & Weekly High Return Stock Forecasts - newser.com
Is Soleno Therapeutics Inc. stock a smart buy before Fed meetingAnalyst Upgrade & Scalable Portfolio Growth Methods - newser.com
Is Soleno Therapeutics Inc. (6XC) stock good for long term investingAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Published on: 2025-11-04 00:54:52 - newser.com
Soleno Therapeutics Q3 Earnings Preview - MSN
Hot Picks: Investor highlights small-cap opportunities in energy, industrial tech and biotech - BNN Bloomberg
Has Soleno Therapeutics Inc. formed a bullish divergence2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Published on: 2025-11-03 08:08:49 - newser.com
Soleno Therapeutics Inc (SLNO) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus
Will Soleno Therapeutics Inc. stock reach Wall Street targetsTrade Risk Assessment & Consistent Income Trade Recommendations - newser.com
What data driven models say about Soleno Therapeutics Inc.’s future2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Will Soleno Therapeutics Inc. outperform the marketJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
How moving averages guide Soleno Therapeutics Inc. tradingAnalyst Downgrade & Long-Term Safe Investment Plans - newser.com
Order flow analysis tools used on Soleno Therapeutics Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
What hedge fund activity signals for Soleno Therapeutics Inc. stock2025 Trade Ideas & Real-Time Volume Analysis Alerts - newser.com
Moody Aldrich Partners LLC Has $3.48 Million Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
How Soleno Therapeutics Inc. stock benefits from strong dollarJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Soleno Therapeutics, Inc. $SLNO Shares Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Is Soleno Therapeutics Inc. a candidate for recovery play2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Is Soleno Therapeutics Inc. stock a bargain at current levelsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Will Soleno Therapeutics Inc. stock benefit from upcoming earnings reportsMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Soleno Therapeutics (SLNO): Assessing Valuation Following Securities Probe and Short-Seller Safety Allegations - Sahm
Strategies to average down on Soleno Therapeutics Inc.July 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
Will Soleno Therapeutics Inc. stock outperform tech sector in 2025Portfolio Return Report & Safe Entry Zone Identification - newser.com
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO - Bluefield Daily Telegraph
Soleno Therapeutics (SLNO) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Soleno Therapeutics Inc (SLNO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):